REVANESSE referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Revanesse Contour™+
Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.
Principales ventajas de Revanesse Contour™+
- Cross-linked hyaluronic acid 25 mg/mL with lidocaine 3 mg/mL for injection comfort
- Indicated for medium to deep facial rhytides
- Covers volume restoration, lip augmentation, skin hydration and contouring of depressions
- Also indicated for volume lost to lipoatrophy or lipodystrophy, including HIV-associated cases
- Supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles
- CE marked 0653 for the syringe, with CE 0123 needles
Indicaciones y uso profesional
Indicaciones principales
- Medium to deep facial rhytides
- Restoration of volume lost from lipoatrophy or lipodystrophy
- Correction of contour deficiencies and anatomic deformities of the facial soft tissue, of pathologic origin or after trauma
- Volume restoration
- Lip augmentation
- Skin hydration
- Contouring of depressions
Uso profesional
For professional use. Revanesse Contour+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. The area must be thoroughly disinfected and injection performed under sterile conditions. Bring the product to room temperature for 30 minutes before injection, prime the syringe until a small drop appears at the needle tip, then inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, must never be used for breast enlargement or implantation into bone, tendon, ligament or muscle, and must not contact quaternary ammonium salts such as benzalkonium chloride.
Zonas de tratamiento
- Facial soft tissue
- Lips
Perfil del paciente
Intended for patients desiring correction of contour deficiencies and deformities in facial soft tissue, including HIV-associated lipoatrophy and lipodystrophy. It is contraindicated in hypersensitivity to any amide-type local anaesthetic, not only lidocaine, and in all degrees of atrioventricular block, sinus node dysfunction, severe decline in myocardial contractility, porphyria and supraventricular tachycardias. It must not be used in pregnancy or lactation, in anyone under 18, in patients who develop hypertrophic scarring, in patients with acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, or unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. Safety in patients over 65 has not been established.
Cómo funciona Revanesse Contour™+
Contour+ is a space-occupying tissue reconstructive material: the cross-linked hyaluronic acid gel occupies volume in the facial soft tissue where it is placed, correcting contour deficiencies rather than acting on the tissue biologically. Its medical indication is the restoration of volume lost from lipoatrophy or lipodystrophy and the correction of contour deficiencies and anatomic deformities, whether of pathologic origin or following trauma. The lidocaine at 0.3% is present for injection comfort, which is also why hypersensitivity to amide-type anaesthetics is an outright contraindication rather than a caution.
Por qué comprar en Allpara
Allpara ofrece productos REVANESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.
Is there a limit on how much can be injected in a year?
Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.
Más productos de Prollenium Medical Technologies
Alternativas para la clínica
Retome donde lo dejó
Revanesse Contour™+
Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.
Principales ventajas de Revanesse Contour™+
- Cross-linked hyaluronic acid 25 mg/mL with lidocaine 3 mg/mL for injection comfort
- Indicated for medium to deep facial rhytides
- Covers volume restoration, lip augmentation, skin hydration and contouring of depressions
- Also indicated for volume lost to lipoatrophy or lipodystrophy, including HIV-associated cases
- Supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles
- CE marked 0653 for the syringe, with CE 0123 needles
Indicaciones y uso profesional
Indicaciones principales
- Medium to deep facial rhytides
- Restoration of volume lost from lipoatrophy or lipodystrophy
- Correction of contour deficiencies and anatomic deformities of the facial soft tissue, of pathologic origin or after trauma
- Volume restoration
- Lip augmentation
- Skin hydration
- Contouring of depressions
Uso profesional
For professional use. Revanesse Contour+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. The area must be thoroughly disinfected and injection performed under sterile conditions. Bring the product to room temperature for 30 minutes before injection, prime the syringe until a small drop appears at the needle tip, then inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, must never be used for breast enlargement or implantation into bone, tendon, ligament or muscle, and must not contact quaternary ammonium salts such as benzalkonium chloride.
Zonas de tratamiento
- Facial soft tissue
- Lips
Perfil del paciente
Intended for patients desiring correction of contour deficiencies and deformities in facial soft tissue, including HIV-associated lipoatrophy and lipodystrophy. It is contraindicated in hypersensitivity to any amide-type local anaesthetic, not only lidocaine, and in all degrees of atrioventricular block, sinus node dysfunction, severe decline in myocardial contractility, porphyria and supraventricular tachycardias. It must not be used in pregnancy or lactation, in anyone under 18, in patients who develop hypertrophic scarring, in patients with acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, or unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. Safety in patients over 65 has not been established.
Cómo funciona Revanesse Contour™+
Contour+ is a space-occupying tissue reconstructive material: the cross-linked hyaluronic acid gel occupies volume in the facial soft tissue where it is placed, correcting contour deficiencies rather than acting on the tissue biologically. Its medical indication is the restoration of volume lost from lipoatrophy or lipodystrophy and the correction of contour deficiencies and anatomic deformities, whether of pathologic origin or following trauma. The lidocaine at 0.3% is present for injection comfort, which is also why hypersensitivity to amide-type anaesthetics is an outright contraindication rather than a caution.
Por qué comprar en Allpara
Allpara ofrece productos REVANESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.
Is there a limit on how much can be injected in a year?
Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.